Fengxian is a small and medium-sized enterprise science and technology innovation vitality area, has always focused on and cultivated basic theoretical innovation, underlying technological innovation, subversive project innovation, cross-border integration innovation, transfer and transformation innovation, a large number of original and disruptive scientific and technological innovation achievements have emerged, becoming a new driving force for Fengxian to cultivate and develop new quality productivity. Since July 16th, the Fengxian District Financial Media Center has focused on "scientific and technological innovation leading the construction of a modern industrial system", focusing on a number of Fengxian enterprises with disruptive technologies, organizing theme interview activities, telling innovation stories from a first-line perspective, and comprehensively helping Fengxian to build an important carrying area for Shanghai's advanced manufacturing industry, the preferred area for cutting-edge technology transformation, a talent innovation and entrepreneurship vitality area, and an ecological and livable industry-city integration area, so as to create a good atmosphere for the upcoming Ninth Plenary Session of the Fifth Committee of Fengxian District of the Communist Party of China in Shanghai.
We all know that in the process of surgery, hemorrhage is a very critical thing, especially the hemorrhage of arteries and major organs, whether it can quickly stop bleeding has become the focus of research in the field of many biomedical materials. But in fact, there is a "magic glue" that has long been applied, making rapid hemostasis a reality. And this subdivision is also the direction of production, education and research that Professor Zhu Linyong, the founder of Shanghai Lingzhuo Medical Technology Co., Ltd. (hereinafter referred to as "Lingzhuo Medical"), who settled in Fengxian last year.
As early as many years ago, Professor Zhu Linyong led the team to invent a bionic hydrogel material that can completely stop aortic damage and heart penetrating hemorrhage in a few seconds.
It is understood that Professor Zhu Linyong, the founder of "Lingzhi Medical", is an internationally renowned expert in photochemistry and biomaterials, focusing on biomedical materials for a long time, and the "photocoupling reaction" gel technology pioneered by his team has distinctive academic characteristics and international leading level, and is the first in the world to realize the ultrafast large-scale manufacturing of high-strength hydrogels (Nat. Mater., 2023, 22, 1263), paving the way for hydrogel materials to be transferred from academia to industry.
As a platform company, Lingzhuo Medical has built a number of disruptive underlying technology platforms such as the world's leading light-curing hydrogels, active hydrogels and the refining and chemical modification of biological macromolecules. Based on the first two technology platforms, the first-in-clas product pipeline provides systematic solutions for multiple key medical departments such as ophthalmology, stomatology, gastroenterology, thoracic surgery, and burn plastic surgery. Not only that, its original technology platform of "refining and chemical modification of biological macromolecules" has enabled the company to complete the kilogram-level mass production of biological macromolecules, and can continue to provide cosmetic-grade and sterile low-endotoxin medical-grade raw materials for the beauty and health industry.
Project research, pilot scale-up, to formal transformation, registration and declaration...... After more than ten years of incubation and development at home and abroad, a year ago, the company quietly settled in Fengxian. There was no roadshow, and there was no initiative to apply for government policy support. "I want to be inconspicuous among the many industry giants in Oriental Beauty Valley with our scale." Recalling the scene when he first arrived in Fengxian, Zhu Linyong still feels pleasantly surprised, and the relevant departments actively organize enterprise discussions, coordinate and assist enterprises to land and transform and apply for new product registration at all levels, "They have a one-stop service platform for enterprise access, industry and commerce, taxation, safety supervision, environmental protection and other affairs, and professionally and efficiently handle various administrative review and approval work for enterprises, which greatly improves the operational efficiency and product transformation efficiency of enterprises." ”
In fact, as early as 2022, after the completion of the A round of financing, the group's headquarters and R&D center were officially registered in the core area of Fengxian Oriental Beauty Valley. In the same year, the company registered Guanghe (Shanghai) Medical Technology Co., Ltd. in the same region, aiming to build the group's second production and manufacturing center to undertake the research and development and manufacturing tasks of innovative products in the future.
According to reports, in the serious medical field, the company has developed a variety of high-end consumables for Class II and Class III medical devices, so as to achieve "the listed generation, the reserve generation, and the R&D generation" to ensure the sustainable competitive advantage of products and technologies. Two entry-level products have completed multi-center clinical trials, among which, the light-curing wound sealant product has been approved for the national special examination qualification for innovative medical devices, and it is expected that two Class III medical device certificates will be approved in 2025. At the same time, in the subdivisions of war trauma and emergency products, plastic surgery and civilian products, enterprises have unique and significant competitiveness. At present, a number of international and domestic head C-end companies have issued clear cooperation invitations to enterprises for cooperative R&D, OEM R&D, technology authorization, OEM and so on.
Since settling down, Lingzuo Medical has taken root in Oriental Beauty Valley, and the new plant is also in full swing, which is also highly valued in the district. "From an academic point of view, the district leaders discovered the unique advantages of the enterprise in the professional segmentation track, came to the enterprise to investigate and pointed out the huge development opportunities of our company's unique technology in the military-civilian integration and civilian market, and strengthened our determination to take root in the long-term development of Fengxian." "We believe that with the superior resources of Shanghai and Fengxian, as well as our strong R&D team and partners, we will be able to accelerate the development of innovative new biomaterial transformation projects." ”
In the future, Lingzhi Medical will continue to deepen the field of transformation of innovative new biological materials, and strive to achieve more significant results in the industry by continuously improving its technology research and development capabilities and market competitiveness. Zhu Linyong said: "We will build an advanced green factory in the core area of Fengxian Oriental Beauty Valley that meets international biomedical R&D and intelligent manufacturing standards, continue to deepen scientific and technological innovation, focus on talent introduction and training, and build an elite R&D team." At the same time, we will increase technology research and development efforts, constantly break through technical bottlenecks, and lead the industry forward. ”